Section 1-Arthritis in Canada
- Treatment options are often tailored to the individual
- The range of public and private drug insurance in Canada
- Drug availability
Section 2—Results and analysis
- Variances in drug costs
- Access depends on where you live
- Variances in access to arthritis drugs
- Public coverage lags behind private insurance programs
Section 3—Conclusions, discussion, and policy implications
Appendix A—Methodology
Appendix B—Multiple indication rates
Appendix C—Active ingredients in arthritis medications
Appendix D—Arthritis active ingredients unique to private payers, 2017
Appendix E—Public plans by province
Appendix F—Bibliography